Chikusetsu saponin IVA induces apoptosis and mitochondrial dysfunction of benign prostatic hyperplasia epithelial cell line (BPH-1) by inhibiting JAK/STAT3 signaling pathway

نویسندگان

چکیده

Purpose: To determine the potential effect of Chikusetsu saponin IVA (CS-IVA) on benign prostatic hyperplasia (BPH), as well mechanism action.
 Methods: Benign epithelial cell response to treatment by CS-IVA was evaluated 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), colony formation assay, and cycle analysis. Flow cytometry immunoblot assay were used assess apoptosis. Mitochondrial damage examined JC-1 staining immunoblot, while also performed JAK/STAT3 pathway.
 Results: inhibited growth progression BPH-1 but promoted apoptosis (p < 0.01). It exacerbated mitochondrial in lines With regard action, pathway cells 0.01).
 Conclusion: induces dysfunction inhibiting pathway, thus it is a drug for BPH. However, vivo studies are required validate these results

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Benign Prostatic Hyperplasia (bph)

Comprehensive studies show that the holmium laser is ideal for treating BPH. Holmium laser treatments have been the most rigorously investigated BPH techniques. Over 90 articles have been published from 8 randomized clinical trials and over 30 case studies and comparative series. The American, European, British and Australasian urology associations recommend holmium laser for BPH treatment. Hol...

متن کامل

Inflammatory Responses in a Benign Prostatic Hyperplasia Epithelial Cell Line (BPH-1) Infected with Trichomonas vaginalis.

Trichomonas vaginalis causes the most prevalent sexually transmitted infection worldwide. Trichomonads have been detected in prostatic tissues from prostatitis, benign prostatic hyperplasia (BPH), and prostate cancer. Chronic prostatic inflammation is known as a risk factor for prostate enlargement, benign prostatic hyperplasia symptoms, and acute urinary retention. Our aim was to investigate w...

متن کامل

Surgical Options for Benign Prostatic Hyperplasia (BPH)

In 1788 John Hunter first described the pathology of prostatic hyperplasia and its effects on the upper urinary tract. It took a century for the first suprapubic prostatectomy to be carried out in 1887 by AF McGill in Leeds (though Americans tend to claim credit to Fuller in New York in 1894.) The procedure was subsequently p o p u l a r i s e d b y S i r Pe t e r F r e ye r . R e t r o p u b i...

متن کامل

Possibilities and Limitations of Phytotherapy for Benign Prostatic Hyperplasia (BPH)

Surgical treatment (transurethral resection or open surgical enucleation of the adenoma) of benign prostatic hyperplasia (BPH) is still the only curative therapy and therefore the "gold standard" for the treatment of BPH. Other treatment modalities have to be judged according to this standard. Despite all improvements in surgical technique and modern anesthesiology, a perioperative mortality ra...

متن کامل

Serum Biochemical and Hematological Parameters in Dogs with Benign Prostatic Hyperplasia (BPH)

BACKGROUND: Clinical prostatic diseases occur in 80% of dogs over 5 and 95% over 9 years of age. . It seems that benign prostatic hyperplasia) BPH) affect Scottish terriers more severely than the other breeds. OBJECTIVES: This study aimed to evaluate the changes of biochemical and hematological parameters in BPH dogs. METHODS: Blood samples were collected from 10 male dogs older than five year...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Tropical Journal of Pharmaceutical Research

سال: 2023

ISSN: ['1596-5996', '1596-9827']

DOI: https://doi.org/10.4314/tjpr.v21i11.7